Advancements in Radioligand Therapy: Implementation, Patient Care, and Waste Management

Radioligand therapy (RLT) physicians, technologists, physicists, and anyone interested in RLT should not miss this Fireside Chat with Charles Ezell, Jr., DHSc, MS, RT(N)(ARRT) from Novartis Pharmaceuticals Corporation. Dr. Ezell gives an overview of the therapy and its significance in treating prostate cancer, along with discussing the latest advancements in the field. Viewers will learn about implementing RLT into a department, the criteria for patient discharge, best practices for patient care during and after treatment, effective waste handling and management techniques, safety protocols, and regulations.